Home » Newsletters » BioWorld Science

BioWorld Science

March 27, 2015

View Archived Issues

JNJ-54861911: promising drug candidate provides stable Abeta reduction

LPCAT-1 implicated in the evolution and progression of breast cancer

Garvan Institute scientists receive support from the Michael J. Fox Foundation

Ocata Therapeutics licenses iPSC technology from Allele Biotechnology

PET imaging of CD4/sr39tk mice enables in vivo tracking of T cells

Novel radiolabeled anti-PSMA nanobody for detection and treatment of prostate cancer

BioLineRx reports topline data for novel stem cell mobilization treatment

Inception 2 patents dual PPARalpha and -delta antagonists

Alexar Therapeutics presents new LXR-beta modulators

NGM Biopharmaceuticals reports phase II data for NGM-282 in primary biliary cirrhosis

Lupin and Indian Rotary Club launch campaign against tuberculosis

Merck & Co. designs small-molecule inhibitors of Hdm2-p53 interaction

Signum Dermalogix licenses SIG-990 to Dermata Therapeutics

Trelagliptin gains first approval in Japan

Daewoong Pharmaceutical presents novel antifungals

Carna Biosciences discloses novel BTK inhibitors

Roche reports development of CB2 receptor agonists

Cladribine receives U.S. orphan drug designation for neuromyelitis optica

Japan Tobacco describes new RORgamma antagonists

European Commission approves Mysimba for weight management

Japanese approval sought for E Keppra as adjunctive therapy for generalized tonic-clonic seizures

Actelion's Opsumit approved in Japan for pulmonary arterial hypertension

MorphoSys regains rights to MOR-202 from Celgene

Aridis starts clinical development of monoclonal antibody against Pseudomonas aeruginosa

Ebola virus vaccines cAd3-EBOZ and VSV-ZEBOV appear to be safe in phase II trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...